MUM-1 Lymphoma Classification | Lahalak Platform
Specialized analysis for classifying aggressive lymphomas, providing vital information on disease progression and expected treatment response to achieve the best possible health outcomes.
Scientific name: MUM-1 Immunohistochemistry Test
Immunohistochemical assay for MUM-1 (Multiple Myeloma Oncogene 1/IRF4) aims to detect this nuclear transcription factor expressed in activated B lymphocytes and in the terminal stages of B cell differentiation (plasma cells). It is primarily used to classify diffuse large B-cell lymphoma (DLBCL) into two subtypes: an activated B-cell (ABC) subtype...
Service type
Laboratory test (Tissue)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis for the detection of the transcription factor MUM-1/IRF4 in tissue samples
- Consult a hematologist or pathologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is tissue-based (lymph node biopsy or tumor tissue).
- The tissue sample must be immediately preserved in 10% formalin.
- This analysis is routinely requested on all new DLBCL cases as part of immunohistochemical classification.
- It is always required within the DLBCL classification package which includes CD10, BCL6, and often BCL2 and Ki-67.
Medical services you might also like
